The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer.
V. Espeli
No relevant relationships to disclose
E. Zucca
No relevant relationships to disclose
M. E. G. Ghielmini
No relevant relationships to disclose
A. Richetti
No relevant relationships to disclose
O. Giannini
No relevant relationships to disclose
F. Martucci
No relevant relationships to disclose